Institut Pasteur opens new branch at the University of São Paulo

Institut Pasteur

French President Emmanuel Macron unveiled Institut Pasteur de São Paulo (IPSP) during a visit to the city on 27 March.

Located on the campus of the University of São Paulo (USP) in a 2,000-square-meter building, the newest member of the Pasteur Network has the capacity to house some 100 scientists working in 17 laboratories, four of which are Biosafety Level Three (BSL3) facilities, as well as a bioinformatics unit and several items of multiuser equipment.

The team’s main research focus is the study of emerging, re-emerging, neglected and degenerative diseases, especially those capable of affecting the health of the central nervous system and neurodevelopment.

“I believe research and academic ties are very important. They aren’t foreign to the political period. There’s a very profound scientific and intellectual history between our two countries. [The work] you’re doing as researchers and professors in partnership with other laboratories affiliated with the Pasteur Network is more solid than the vicissitudes of time. Thank you for devoting so many years of your lives,” Macron said.

Full member of the Pasteur Network

The São Paulo branch of the network will continue the work that has been done since 2017 with The São Paulo Research Foundation’s (FAPESP) support under the aegis of the Scientific Platform Pasteur-USP (SPPU).

In July 2022, USP and the São Paulo State Government signed an agreement with France’s Institut Pasteur to convert SPPU into a full member of the Pasteur Network, which comprises 33 labs in 25 countries.

“SPPU was an excellent initiative in itself, but Institut Pasteur de São Paulo really establishes the link between our two institutions,” said Carlos Gilberto Carlotti Junior, Rector of USP. “We can use funds from both institutions, and we can pursue other ways to fund the research autonomously, as well as belonging to the Pasteur Network, which has labs all over the world. This gives the institution a fresh perspective and should lead to an increase in the number of researchers.”

Diana Spencer, Senior Digital Content Editor, DDW

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free